Sign up for free to listen for longer

Get unlimited radio, access to exclusive and original podcasts and non-stop music stations.

Control the way you listen to your favourite music, podcasts and radio.

Already have an account?

Log in

Sign up for free to listen for longer

Get unlimited radio, access to exclusive and original podcasts and non-stop music stations.

Control the way you listen to your favourite music, podcasts and radio.

Already have an account?

Log in

Ozempic Wars | The Hundred-Year Duel | 1

Ozempic Wars | The Hundred-Year Duel | 1

Business Wars
Sea. 122 Ep. 134 min
19 Nov 25
Mark as played
Share

About the episode

When pharmaceutical giant Novo Nordisk developed a new medication for type 2 diabetes, they noticed that a welcome side effect was a small amount of weight loss. They had no idea that their new diabetes medication was about to become a multibillion-dollar weight loss drug. But they had no sooner launched this game-changing drug, then competitors swooped in to knock Novo Nordisk off its throne.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.